Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study

BACKGROUND: Metastatic colorectal cancer (mCRC) is a major cause of death of malignant tumor and the valuable prognostic biomarker for chemotherapy is crucial in decreasing mortality. Previous studies have proved the prognostic value of the mean platelet volume (MPV) in survival of primary operable...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jinjia, Lin, Guangyi, Ye, Min, Tong, Duo, Zhao, Jing, Zhu, Dan, Yu, Qihe, Zhang, Wen, Li, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322328/
https://www.ncbi.nlm.nih.gov/pubmed/30612568
http://dx.doi.org/10.1186/s12885-018-5252-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322328/
https://www.ncbi.nlm.nih.gov/pubmed/30612568
http://dx.doi.org/10.1186/s12885-018-5252-2

Ejemplares similares